{
    "clinical_study": {
        "@rank": "99062", 
        "arm_group": [
            {
                "arm_group_label": "Bifidobacterium lactis", 
                "arm_group_type": "Active Comparator", 
                "description": "5 billion Bifidobacterium lactis"
            }, 
            {
                "arm_group_label": "\u0130nulin", 
                "arm_group_type": "Active Comparator", 
                "description": "900 mg \u0130nulin per day will be given"
            }, 
            {
                "arm_group_label": "Maltodextrin", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Maltodextrin"
            }, 
            {
                "arm_group_label": "Bifidobacterium lactis plus \u0130n\u00fclin", 
                "arm_group_type": "Active Comparator", 
                "description": "5 billion active Bifidobacterium lactis plus 900 mg \u0130n\u00fclin per day"
            }
        ], 
        "brief_summary": {
            "textblock": "Study, the inclusion of very low birth weight premature infants followed in Dr.Sami Ulus\n      Maternity and Children Training and Research Hospital, Department of Neonatology; be\n      randomized to very low birth weight premature infants began eating until you are discharged\n      from the hospital once a day to feed a group+ 900 mg of 5 billion active Bifidobacterium\n      lactis, the addition of chicory inulin, in the other group given placebo; Patients taking\n      weekly blood cultures, the presence of residues in both groups during feeding, to evaluate\n      the incidence of NEC and sepsis are planned. Randomization and the number of patients\n      planned to separate into groups."
        }, 
        "brief_title": "The Effects of Synbiotics on Morbidity and Mortality in Preterm Infants", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Necrotizing Enterocolitis", 
            "Sepsis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Enterocolitis", 
                "Sepsis", 
                "Enterocolitis, Necrotizing"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients separated into four groups using the sealed envelope method."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  VLBW infants admitted to NICU at the first 7 days of life\n\n        Exclusion Criteria:\n\n          -  expected life lower than 7 days,\n\n          -  babies who could not be fed (any metabolic disorders, gastrointestinal system\n             surgical disorders etc.),\n\n          -  severe asphyxia,\n\n          -  severe congenital anomaly"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "30 Days", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01807858", 
            "org_study_id": "68/16.Oct.2012"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "\u0130nulin", 
                    "Maltodextrin", 
                    "Bifidobacterium lactis plus \u0130n\u00fclin"
                ], 
                "description": "5 billion active Bifidobacterium lactis", 
                "intervention_name": "Bifidobacterium lactis", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Bifidobacterium lactis"
            }, 
            {
                "arm_group_label": [
                    "Bifidobacterium lactis", 
                    "\u0130nulin", 
                    "Maltodextrin"
                ], 
                "description": "5 billion Bifidobacterium lactis plus 900 mg \u0130n\u00fclin per day will be given", 
                "intervention_name": "Bifidobacterium lactis plus \u0130n\u00fclin", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "5 billion Bifidobacterium lactis plus 900 mg \u0130n\u00fclin"
            }, 
            {
                "arm_group_label": [
                    "Bifidobacterium lactis", 
                    "\u0130nulin", 
                    "Bifidobacterium lactis plus \u0130n\u00fclin"
                ], 
                "description": "Maltodextrin", 
                "intervention_name": "Maltodextrin", 
                "intervention_type": "Other", 
                "other_name": "Maltodextrin"
            }, 
            {
                "arm_group_label": [
                    "Bifidobacterium lactis", 
                    "Maltodextrin", 
                    "Bifidobacterium lactis plus \u0130n\u00fclin"
                ], 
                "description": "900 mg inulin per day will be given", 
                "intervention_name": "\u0130nulin", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "\u0130nulin"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Necrotizing enterocolitis", 
            "Sepsis", 
            "Length of hospital stay", 
            "Mortality"
        ], 
        "lastchanged_date": "March 7, 2013", 
        "link": {
            "description": "Are Probiotics Safe For Newborns? / LIVESTRONG.COM", 
            "url": "http://www.livestrong.com/article/468506-are-probiotics-safe-for-newborns/"
        }, 
        "location": [
            {
                "contact": {
                    "last_name": "Arzu Akda\u011f, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Bursa", 
                        "country": "Turkey"
                    }, 
                    "name": "\u015eevket Y\u0131lmaz Research Hospital"
                }, 
                "investigator": {
                    "last_name": "Arzu Akda\u011f, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Banu Mutlu, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Diyarbak\u0131r", 
                        "country": "Turkey"
                    }, 
                    "name": "Diyarbak\u0131r Research Hospital"
                }, 
                "investigator": {
                    "last_name": "M. \u015eah O\u011fuz, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "\u015eenol Bozda\u011f, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "\u0130stanbul", 
                        "country": "Turkey"
                    }, 
                    "name": "Umraniye Research Hospital"
                }, 
                "investigator": {
                    "last_name": "\u015eenol Bozda\u011f", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "\u00d6zden Turan, MD"
                }, 
                "contact_backup": {
                    "last_name": "\u00d6zden Turan"
                }, 
                "facility": {
                    "address": {
                        "city": "\u0130stanbul", 
                        "country": "Turkey"
                    }, 
                    "name": "Okmeydani Research Hospital"
                }, 
                "investigator": {
                    "last_name": "\u00d6zden Turan, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "4", 
        "official_title": "The Effects of Synbiotics on Morbidity and Mortality in Preterm Infants", 
        "overall_contact": {
            "last_name": "Dilek Dilli, Assoc Prof", 
            "phone": "00903123055000"
        }, 
        "overall_official": {
            "affiliation": "Assoc Prof", 
            "last_name": "Dilek Dilli, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Turkey: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Developing of >= grade 2 necrotizing enterocolitis suggested by radiological investigation", 
            "measure": "Necrotizing enterocolitis", 
            "safety_issue": "No", 
            "time_frame": "8 weeks"
        }, 
        "reference": {
            "PMID": "22572829", 
            "citation": "Fouhy F, Ross RP, Fitzgerald GF, Stanton C, Cotter PD. Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps. Gut Microbes. 2012 May-Jun;3(3):203-20. doi: 10.4161/gmic.20169. Epub 2012 May 1. Review."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01807858"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Dr. Sami Ulus Children's Hospital", 
            "investigator_full_name": "Dilek Dilli", 
            "investigator_title": "Assoc Prof", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "length of hospital stay", 
            "measure": "length of hospital stay", 
            "safety_issue": "No", 
            "time_frame": "16 weeks"
        }, 
        "source": "Dr. Sami Ulus Children's Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dr. Sami Ulus Children's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}